| MonoMethyl auristatin E |
一甲基澳瑞他汀 E |
474645-27-7 |
| D-Galactose |
D-半乳糖 |
59-23-4 |
| DSHS00884 |
DSHS00884 |
675104-49-1 |
| Acetamide,N-(2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)- |
3-乙酰氨基邻苯二甲酰亚胺 |
6118-65-6 |
| CDK4/6-IN-4 |
CDK4/6-IN-4 |
2138499-06-4 |
| BI-3812 |
CPD1815 |
2166387-64-8 |
| 3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene |
3-(4-溴苯基)-4-氧代-7-[(甲磺酰基)氧基]-4H-色烯 |
610753-87-2 |
| FB23-2 |
FB23-2 |
2243736-45-8 |
| 2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
阿托伐他汀钙杂质21(钙盐) |
929540-41-0 |
| BMS-470539 dihydrochloride |
BMS 470539 DIHYDROCHLORIDE |
2341796-82-3 |
| BTK inhibitor 10 |
BTK inhibitor 10 |
2241732-30-7 |
| GLUT4 activator 1 |
GLUT4 activator 1 |
2253733-37-6 |
| PF-06928215 |
PF-06928215 |
2378173-15-8 |
| SM-164 |
SM 164 |
957135-43-2 |
| 4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
2314467-59-7 |
| 1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)- |
化合物 T10476 |
2471967-92-5 |
| 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- |
XL092 |
2367004-54-2 |
| Methanone, (2,6-dimethyl-4-pyridinyl)[4-[7-(trans-4-hydroxycyclohexyl)-2-[[(1S)-1-methylbutyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-1-piperidinyl]- |
化合物 T9134 |
2226789-82-6 |
| Urea, N-(3-chlorophenyl)-N'-(6-cyano-2-benzothiazolyl)- |
HB007 |
2387821-46-5 |
| Uliledlimab |
尤莱利单抗 |
2378407-27-1 |
QQ
微信
